Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TK inhibitors disclosed by Pfizer

March 4, 1997

Takeda describes antitumor agents

March 4, 1997

Novel antitumor agents disclosed by Yale University

March 3, 1997

Kyowa Hakko discloses DC-107 derivatives

March 3, 1997

DepoTech initiates pediatric clinical trial DepoCyt

Feb. 28, 1997

Somatostatin peptides prepared by Novartis

Feb. 28, 1997

Yamanouchi prepares hormonal agents for testosterone-dependent disorders

Feb. 28, 1997

Cytotoxic colchicine derivatives from Indena

Feb. 27, 1997

Third pivotal trial for lisofylline

Feb. 26, 1997

New approach to brain cancer introduced

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...